Can neoadjuvant chemotherapy change clinic pathological and survival parameters in HER-2 positive breast cancer patients?

被引：0
|
作者：
Mundim, F. [1 ]
Franco, A. [1 ]
Infante, K. [1 ]
Neto, J. [1 ]
Brentani, M. M. [1 ]
Facina, G. [1 ]
Waitzberg, A. [1 ]
机构：
[1] Univas Brazil, Pathol, Pouso Alegre, Brazil
来源：
VIRCHOWS ARCHIV | 2018年 / 473卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-02-04
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [11] HER-2/neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer
    Tulbah A.M.
    Ibrahim E.M.
    Ezzat A.A.
    Ajarim D.S.
    Rahal M.M.
    El Weshi A.N.
    Sorbris R.
    Medical Oncology, 2002, 19 (1) : 15 - 23
  • [12] HER-2/neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer
    Tulbah, AM
    Ibrahim, EM
    Ezzat, AA
    Ajarim, DS
    Rahal, MM
    El Weshi, AN
    Sorbris, R
    MEDICAL ONCOLOGY, 2002, 19 (01) : 15 - 23
  • [13] Her-2 Breast Cancer Treatments Induced Variations in the Patterns of Survival and Metastasis in Her-2 Positive Breast Cancers
    McGuire, A.
    Kalinina, O.
    Holian, E.
    Sweeney, K.
    Malone, C.
    McLaughlin, R.
    Lowery, A.
    Brown, J. A. L.
    Kerin, M. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S397 - S397
  • [14] The impact of neoadjuvant chemotherapy on overall survival in patients with early-stage HER2-positive breast cancer
    Champion, Nicholas
    Azab, Basem
    Abeysekera, Aravinda
    Kim, Sara
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 201 - 201
  • [15] Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy
    Stjepanovic, Neda
    Kumar, Sudhir
    Jerzak, Katarzyna J.
    Trudeau, Maureen
    Warner, Ellen
    Cao, Xingshan
    Eisen, Andrea
    Tran, William
    Pezo, Rossanna C.
    CLINICAL BREAST CANCER, 2024, 24 (08) : e723 - e730
  • [16] The Efficacy of Neoadjuvant Chemotherapy for HER-2-Positive Locally Advanced Breast Cancer and Survival Analysis
    Zhang, Wei
    Tian, Huan
    Yang, Shi-hong
    ANALYTICAL CELLULAR PATHOLOGY, 2017, 2017
  • [17] Prognostic Factors for Locoregional Recurrence in HER-2 Overexpressing Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Arsenault, D. M.
    Hurley, J.
    Reis, I.
    Zhao, W.
    Takita, C.
    Gomez, C.
    Jorda, M.
    Cioffi-Lavina, M.
    Villasboas, J. C.
    Wright, J. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S225 - S225
  • [18] Predictors of complete pathological response to neoadjuvant chemotherapy in patients with HER2 overexpressing breast cancer
    Boudaouara, O.
    Ben Makhlouf, W.
    Makni, S.
    Mellouli, M.
    Ben Kridis, W.
    Boudawara, T. Sellami
    Chaari, C.
    VIRCHOWS ARCHIV, 2024, 485 : S189 - S190
  • [19] Effect of neoadjuvant chemotherapy on oestrogen, progesterone, and HER-2 receptor expression in breast cancer
    Sircar, T.
    Chaudhri, S.
    Francis, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [20] Effect of bodymass index on survival outcomes of patients with HER-2 positive advanced breast cancer
    Modi, Natansh D.
    Koczwara, Bogda
    Rowland, Andrew
    McKinnon, Ross A.
    Wiese, Michael D.
    Sorich, Michael J.
    Hopkins, Ashley M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 128 - 128
12345